Skip to main content
. 2017 May 17;20(2):253–262. doi: 10.1093/europace/eux022

Figure 4.

Figure 4

Distribution of the time in therapeutic range in the warfarin group according to the absence or presence of left ventricular hypertrophy. LVH, left ventricular hypertrophy.